Skip Navigation

Elizabeth H. Baldini, MD, MPH


Radiation Oncology

Make an Appointment

Physician

  • Director, Radiation Oncology, Center for Sarcoma and Bone Oncology
  • Institute Physician
  • Associate Professor of Radiation Oncology, Harvard Medical School

Clinical Interests

  • Sarcomas
  • Thoracic malignancies

Diseases Treated

Contact Information

  • Appointments(617) 632-4739
  • Office Phone Number617-732-7936
  • Fax617-582-7726

Board Certification:

  • Radiation Oncology, 1993

Residency:

  • Harvard Joint Center for Radiation Therapy, Radiation Oncology
  • Harvard Joint Center for Radiation Therapy, Radiation Oncology, Chief Resident

Medical School:

  • Harvard Medical School

Recent Awards:

  • American Society of Therapeutic Radiation Oncology (ASTRO) Resident Essay Award 1992
  • Von Meyer Award for Clinical Research, Children's Hospital 1992
  • Harvard Medical School 50th Anniversary Program for Scholars in Medicine, Dana-Farber Cancer Institute Fellowship 2000

Research

Hou Y, Hermann G, Lewis JH, Aerts HJ, Baldini EH, Chen AB, Colson YL, Hacker FL, Killoran JH, Kozono DE, Wagar M, Wee JO, Mak RH. Clinical Outcomes After Lung Stereotactic Body Radiation Therapy in Patients With or Without a Prior Lung Resection. Am J Clin Oncol. 2018 Jul; 41(7):695-701.
View in: PubMed

Haas RL, Gronchi A, van de Sande MAJ, Baldini EH, Gelderblom H, Messiou C, Wardelmann E, Le Cesne A. Perioperative Management of Extremity Soft Tissue Sarcomas. J Clin Oncol. 2018 Jan 10; 36(2):118-124.
View in: PubMed

Erstad DJ, Ready J, Abraham J, Ferrone ML, Bertagnolli MM, Baldini EH, Raut CP. Amputation for Extremity Sarcoma: Contemporary Indications and Outcomes. Ann Surg Oncol. 2018 Feb; 25(2):394-403.
View in: PubMed

Haas RL, Baldini EH, Chung PW, van Coevorden F, DeLaney TF. Radiation therapy in retroperitoneal sarcoma management. J Surg Oncol. 2018 Jan; 117(1):93-98.
View in: PubMed

Diao K, Chen YH, Catalano PJ, Lee S, Milani N, Killoran JH, Baldini EH, Chen AB, Kozono DE, Mak RH. Radiation toxicity in patients with collagen vascular disease and intrathoracic malignancy treated with modern radiation techniques. Radiother Oncol. 2017 11; 125(2):301-309.
View in: PubMed

Fairweather M, Wang J, Jo VY, Baldini EH, Bertagnolli MM, Raut CP. Surgical Management of Primary Retroperitoneal Sarcomas: Rationale for Selective Organ Resection. Ann Surg Oncol. 2018 Jan; 25(1):98-106.
View in: PubMed

Baldini E. Retroperitoneal Sarcoma: Setting the Stage for Treatment Strategies Tailored to Histologic Subtype and Other Patient and Tumor Factors. Int J Radiat Oncol Biol Phys. 2017 10 01; 99(2):292-295.
View in: PubMed

Franco I, Chen YH, Chipidza F, Agrawal V, Romano J, Baldini E, Chen A, Colson Y, Hou Y, Kozono D, Wee J, Mak R. Use of frailty to predict survival in elderly patients with early stage non-small-cell lung cancer treated with stereotactic body radiation therapy. J Geriatr Oncol. 2018 Mar; 9(2):130-137.
View in: PubMed

Kovtun KA, Yeo WP, Phillips CH, Viswanathan A, Baldini EH. Ovary-Sparing Radiation Planning Techniques Can Achieve Ovarian Dose Reduction for Soft Tissue Sarcoma of the Buttock and Thigh. Sarcoma. 2017; 2017:2796925.
View in: PubMed

Royce TJ, Punglia RS, Chen AB, Patel SA, Thornton KA, Raut CP, Baldini EH. Cost-Effectiveness of Surveillance for Distant Recurrence in Extremity Soft Tissue Sarcoma. Ann Surg Oncol. 2017 Oct; 24(11):3264-3270.
View in: PubMed

Baldini EH. The Conundrum of Retroperitoneal Liposarcoma-To Be More Aggressive or Less Aggressive? Int J Radiat Oncol Biol Phys. 2017 06 01; 98(2):269-270.
View in: PubMed

Pretz JL, Barysauskas CM, George S, Hornick JL, Raut CP, Chen YE, Marcus KJ, Choy E, Hornicek F, Ready JE, DeLaney TF, Baldini EH. Localized Adult Ewing Sarcoma: Favorable Outcomes with Alternating Vincristine, Doxorubicin, Cyclophosphamide, and Ifosfamide, Etoposide (VDC/IE)-Based Multimodality Therapy. Oncologist. 2017 10; 22(10):1265-1270.
View in: PubMed

Agrawal V, Coroller TP, Hou Y, Lee SW, Romano JL, Baldini EH, Chen AB, Kozono D, Swanson SJ, Wee JO, Aerts HJWL, Mak RH. Lymph node volume predicts survival but not nodal clearance in Stage IIIA-IIIB NSCLC. PLoS One. 2017; 12(4):e0174268.
View in: PubMed

Schaefer IM, Hornick JL, Barysauskas CM, Raut CP, Patel SA, Royce TJ, Fletcher CDM, Baldini EH. Histologic Appearance After Preoperative Radiation Therapy for Soft Tissue Sarcoma: Assessment of the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group Response Score. Int J Radiat Oncol Biol Phys. 2017 06 01; 98(2):375-383.
View in: PubMed

Fairweather M, Wang J, Jo VY, Baldini EH, Bertagnolli MM, Raut CP. Incidence and Adverse Prognostic Implications of Histopathologic Organ Invasion in Primary Retroperitoneal Sarcoma. J Am Coll Surg. 2017 May; 224(5):876-883.
View in: PubMed

Patel SA, Royce TJ, Barysauskas CM, Thornton KA, Raut CP, Baldini EH. Surveillance Imaging Patterns and Outcomes Following Radiation Therapy and Radical Resection for Localized Extremity and Trunk Soft Tissue Sarcoma. Ann Surg Oncol. 2017 Jun; 24(6):1588-1595.
View in: PubMed

DeLaney TF, Chen YL, Baldini EH, Wang D, Adams J, Hickey SB, Yeap BY, Hahn SM, De Amorim Bernstein K, Nielsen GP, Choy E, Mullen JT, Yoon SS. Phase 1 trial of preoperative image guided intensity modulated proton radiation therapy with simultaneously integrated boost to the high risk margin for retroperitoneal sarcomas. Adv Radiat Oncol. 2017 Jan-Mar; 2(1):85-93.
View in: PubMed

Agrawal V, Coroller TP, Hou Y, Lee SW, Romano JL, Baldini EH, Chen AB, Jackman DM, Kozono D, Swanson SJ, Wee JO, Aerts HJ, Mak RH. Radiologic-pathologic correlation of response to chemoradiation in resectable locally advanced NSCLC. Lung Cancer. 2016 12; 102:1-8.
View in: PubMed

Hou Y, Lee S, Agrawal V, Romano J, Baldini EH, Chen AB, Kozono DE, Killoran JH, Wagar M, Hacker FL, Aerts HJ, Lewis JH, Mak RH. Inter-scan and inter-observer tumour volume delineation variability on cone beam computed tomography in patients treated with stereotactic body radiation therapy for early-stage non-small cell lung cancer. J Med Imaging Radiat Oncol. 2017 Feb; 61(1):93-98.
View in: PubMed

Baldini EH. Defining the role of radiotherapy for retroperitoneal sarcoma. Lancet Oncol. 2016 07; 17(7):857-859.
View in: PubMed

Braschi-Amirfarzan M, Keraliya AR, Krajewski KM, Tirumani SH, Shinagare AB, Hornick JL, Baldini EH, George S, Ramaiya NH, Jagannathan JP. Role of Imaging in Management of Desmoid-type Fibromatosis: A Primer for Radiologists. Radiographics. 2016 May-Jun; 36(3):767-82.
View in: PubMed

Li R, Hermann G, Baldini E, Chen A, Jackman D, Kozono D, Nguyen P, Nohria A, Powell G, Mak R. Advanced nodal stage predicts venous thromboembolism in patients with locally advanced non-small cell lung cancer. Lung Cancer. 2016 06; 96:41-7.
View in: PubMed

Nazarian A, Entezari V, Villa-Camacho JC, Zurakowski D, Katz JN, Hochman M, Baldini EH, Vartanians V, Rosen MP, Gebhardt MC, Terek RM, Damron TA, Yaszemski MJ, Snyder BD. Does CT-based Rigidity Analysis Influence Clinical Decision-making in Simulations of Metastatic Bone Disease? Clin Orthop Relat Res. 2016 Mar; 474(3):652-9.
View in: PubMed

Wortman JR, Tirumani SH, Jagannathan JP, Rosenthal MH, Shinagare AB, Hornick JL, Baldini EH, Ramaiya NH. Radiation Therapy for Soft-Tissue Sarcomas: A Primer for Radiologists. Radiographics. 2016 Mar-Apr; 36(2):554-72.
View in: PubMed

Haas RL, Miah AB, LePechoux C, DeLaney TF, Baldini EH, Alektiar K, O'Sullivan B. Preoperative radiotherapy for extremity soft tissue sarcoma; past, present and future perspectives on dose fractionation regimens and combined modality strategies. Radiother Oncol. 2016 Apr; 119(1):14-21.
View in: PubMed

Mak KS, Phillips JG, Barysauskas CM, Lee LK, Mannarino EG, Van Benthuysen L, Raut CP, Mullen JT, Fairweather M, DeLaney TF, Baldini EH. Acute gastrointestinal toxicity and bowel bag dose-volume parameters for preoperative radiation therapy for retroperitoneal sarcoma. Pract Radiat Oncol. 2016 Sep-Oct; 6(5):360-366.
View in: PubMed

Baldini EH, Wang D, Haas RL, Catton CN, Indelicato DJ, Kirsch DG, Roberge D, Salerno K, Deville C, Guadagnolo BA, O'Sullivan B, Petersen IA, Le Pechoux C, Abrams RA, DeLaney TF. Treatment Guidelines for Preoperative Radiation Therapy for Retroperitoneal Sarcoma: Preliminary Consensus of an International Expert Panel. Int J Radiat Oncol Biol Phys. 2015 Jul 01; 92(3):602-12.
View in: PubMed

Tuccilli C, Baldini E, Sorrenti S, Di Gioia C, Bosco D, Ascoli V, Mian C, Barollo S, Rendina R, Coccaro C, Pepe M, Catania A, Bononi M, Tartaglia F, De Antoni E, D'Armiento M, Ulisse S. PAPILLARY THYROID CANCER IS CHARACTERIZED BY ALTERED EXPRESSION OF GENES INVOLVED IN THE SUMOYLATION PROCESS. J Biol Regul Homeost Agents. 2015 Jul-Sep; 29(3):655-62.
View in: PubMed

Tanguturi SK, George S, Marcus KJ, Demetri GD, Baldini EH. Whole Lung Irradiation in Adults with Metastatic Ewing Sarcoma: Practice Patterns and Implications for Treatment. Sarcoma. 2015; 2015:591698.
View in: PubMed

Baldini EH, Bosch W, Kane JM, Abrams RA, Salerno KE, Deville C, Raut CP, Petersen IA, Chen YL, Mullen JT, Millikan KW, Karakousis G, Kendrick ML, DeLaney TF, Wang D. Retroperitoneal sarcoma (RPS) high risk gross tumor volume boost (HR GTV boost) contour delineation agreement among NRG sarcoma radiation and surgical oncologists. Ann Surg Oncol. 2015 Sep; 22(9):2846-52.
View in: PubMed

Baldini EH, Abrams RA, Bosch W, Roberge D, Haas RLM, Catton CN, Indelicato DJ, Olsen JR, Deville C, Chen YL, Finkelstein SE, DeLaney TF, Wang D. Retroperitoneal Sarcoma Target Volume and Organ at Risk Contour Delineation Agreement Among NRG Sarcoma Radiation Oncologists. Int J Radiat Oncol Biol Phys. 2015 Aug 01; 92(5):1053-1059.
View in: PubMed

Epstein-Peterson ZD, Sullivan A, Krishnan M, Chen JT, Ferrone M, Ready J, Baldini EH, Balboni T. Postoperative radiation therapy for osseous metastasis: Outcomes and predictors of local failure. Pract Radiat Oncol. 2015 Sep-Oct; 5(5):e531-e536.
View in: PubMed

Baldini EH, Richards WG, Gill RR, Goodman BM, Winfrey OK, Eisen HM, Mak RH, Chen AB, Kozono DE, Bueno R, Sugarbaker DJ. Updated patterns of failure after multimodality therapy for malignant pleural mesothelioma. J Thorac Cardiovasc Surg. 2015 May; 149(5):1374-81.
View in: PubMed

Lane JD, Pomahac B, Raut CP, Baldini EH, Devlin PM. High-dose-rate Interstitial Brachytherapy Boost with a Pedicled Latissimus Dorsi Myocutaneous Flap for Myxofibrosarcoma of the Arm. Plast Reconstr Surg Glob Open. 2014 Oct; 2(10):e229.
View in: PubMed

Fairweather M, Wang J, Devlin PM, Hansen J, Baldini EH, Ready JE, Sugarbaker DJ, Bertagnolli MM, Raut CP. Safety and efficacy of radiation dose delivered via iodine-125 brachytherapy mesh implantation for deep cavity sarcomas. Ann Surg Oncol. 2015 May; 22(5):1455-63.
View in: PubMed

Mak RH, Hermann G, Lewis JH, Aerts HJ, Baldini EH, Chen AB, Colson YL, Hacker FH, Kozono D, Wee JO, Chen YH, Catalano PJ, Wong KK, Sher DJ. Outcomes by tumor histology and KRAS mutation status after lung stereotactic body radiation therapy for early-stage non-small-cell lung cancer. Clin Lung Cancer. 2015 Jan; 16(1):24-32.
View in: PubMed

Pan E, Goldberg SI, Chen YL, Giraud C, Hornick JL, Nielsen GP, Hornicek FJ, Raut CP, DeLaney TF, Baldini EH. Role of post-operative radiation boost for soft tissue sarcomas with positive margins following pre-operative radiation and surgery. J Surg Oncol. 2014 Dec; 110(7):817-22.
View in: PubMed

Gray PJ, Mak RH, Yeap BY, Cryer SK, Pinnell NE, Christianson LW, Sher DJ, Arvold ND, Baldini EH, Chen AB, Kozono DE, Swanson SJ, Jackman DM, Alexander BM. Aggressive therapy for patients with non-small cell lung carcinoma and synchronous brain-only oligometastatic disease is associated with long-term survival. Lung Cancer. 2014 Aug; 85(2):239-44.
View in: PubMed

Parikh RB, Cronin AM, Kozono DE, Oxnard GR, Mak RH, Jackman DM, Lo PC, Baldini EH, Johnson BE, Chen AB. Definitive primary therapy in patients presenting with oligometastatic non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2014 Jul 15; 89(4):880-7.
View in: PubMed

Baldini EH, Raut C. Radiation therapy for extremity soft tissue sarcoma: in the absence of a clear survival benefit, why do we give it? Ann Surg Oncol. 2014 Aug; 21(8):2463-5.
View in: PubMed

Coroller TP, Mak RH, Lewis JH, Baldini EH, Chen AB, Colson YL, Hacker FL, Hermann G, Kozono D, Mannarino E, Molodowitch C, Wee JO, Sher DJ, Killoran JH. Low incidence of chest wall pain with a risk-adapted lung stereotactic body radiation therapy approach using three or five fractions based on chest wall dosimetry. PLoS One. 2014; 9(4):e94859.
View in: PubMed

Chirieac LR, Barletta JA, Yeap BY, Richards WG, Tilleman T, Bueno R, Baldini EH, Godleski J, Sugarbaker DJ. Clinicopathologic characteristics of malignant mesotheliomas arising in patients with a history of radiation for Hodgkin and non-Hodgkin lymphoma. J Clin Oncol. 2013 Dec 20; 31(36):4544-9.
View in: PubMed

Gazula A, Baldini EH, Chen A, Kozono D. Comparison of once and twice daily radiotherapy for limited stage small-cell lung cancer. Lung. 2014 Feb; 192(1):151-8.
View in: PubMed

Keung EZ, Hornick JL, Bertagnolli MM, Baldini EH, Raut CP. Predictors of outcomes in patients with primary retroperitoneal dedifferentiated liposarcoma undergoing surgery. J Am Coll Surg. 2014 Feb; 218(2):206-17.
View in: PubMed

Burt BM, Ali SO, DaSilva MC, Yeap BY, Richards WG, Baldini EH, Sugarbaker DJ. Clinical indications and results after chest wall resection for recurrent mesothelioma. J Thorac Cardiovasc Surg. 2013 Dec; 146(6):1373-9; discussion 1379-80.
View in: PubMed

Khandekar MJ, Raut CP, Hornick JL, Wang Q, Alexander BM, Baldini EH. Paratesticular liposarcoma: unusual patterns of recurrence and importance of margins. Ann Surg Oncol. 2013 Jul; 20(7):2148-55.
View in: PubMed

Tiseo M, Bordi P, Bortesi B, Boni L, Boni C, Baldini E, Grossi F, Recchia F, Zanelli F, Fontanini G, Naldi N, Campanini N, Azzoni C, Bordi C, Ardizzoni A. ERCC1/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatin. Br J Cancer. 2013 Apr 30; 108(8):1695-703.
View in: PubMed

Bahig H, Roberge D, Bosch W, Levin W, Petersen I, Haddock M, Freeman C, Delaney TF, Abrams RA, Indelicato DJ, Baldini EH, Hitchcock Y, Kirsch DG, Kozak KR, Wolfson A, Wang D. Agreement among RTOG sarcoma radiation oncologists in contouring suspicious peritumoral edema for preoperative radiation therapy of soft tissue sarcoma of the extremity. Int J Radiat Oncol Biol Phys. 2013 Jun 01; 86(2):298-303.
View in: PubMed

Sugarbaker DJ, Gill RR, Yeap BY, Wolf AS, DaSilva MC, Baldini EH, Bueno R, Richards WG. Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural mesothelioma undergoing surgical macroscopic complete resection. J Thorac Cardiovasc Surg. 2013 Apr; 145(4):955-963.
View in: PubMed

Rusch V, Baldini EH, Bueno R, De Perrot M, Flores R, Hasegawa S, Klepetko W, Krug L, Lang-Lazdunski L, Pass H, Weder W, Sugarbaker DJ. The role of surgical cytoreduction in the treatment of malignant pleural mesothelioma: meeting summary of the International Mesothelioma Interest Group Congress, September 11-14, 2012, Boston, Mass. J Thorac Cardiovasc Surg. 2013 Apr; 145(4):909-910.
View in: PubMed

McBride SM, Raut CP, Lapidus M, Devlin PM, Marcus KJ, Bertagnolli M, George S, Baldini EH. Locoregional recurrence after preoperative radiation therapy for retroperitoneal sarcoma: adverse impact of multifocal disease and potential implications of dose escalation. Ann Surg Oncol. 2013 Jul; 20(7):2140-7.
View in: PubMed

Baldini EH, Lapidus MR, Wang Q, Manola J, Orgill DP, Pomahac B, Marcus KJ, Bertagnolli MM, Devlin PM, George S, Abraham J, Ferrone ML, Ready JE, Raut CP. Predictors for major wound complications following preoperative radiotherapy and surgery for soft-tissue sarcoma of the extremities and trunk: importance of tumor proximity to skin surface. Ann Surg Oncol. 2013 May; 20(5):1494-9.
View in: PubMed

Baldini E, Sorrenti S, Catania A, Guaitoli E, Prinzi N, Mocini R, Nardi F, D'Armiento E, Bianchini M, Favoriti P, Di Matteo FM, Ruggieri M, De Antoni E, Ulisse S. Diagnostic utility of thyroglobulin measurement in the fine needle aspirates from cervical lymph nodes: a case report. G Chir. 2012 Nov-Dec; 33(11-12):387-91.
View in: PubMed

Morgan EA, Kozono DE, Wang Q, Mery CM, Butrynski JE, Baldini EH, George S, Nascimento AF, Raut CP. Cutaneous radiation-associated angiosarcoma of the breast: poor prognosis in a rare secondary malignancy. Ann Surg Oncol. 2012 Nov; 19(12):3801-8.
View in: PubMed

Lewis J, Mak R, Molodowitch C, Mannarino E, Baldini E, Chen A, Kozono D, Sher D, Hacker F, Killoran J. TU-E-BRB-02: A Decision Support Tool for SBRT Planning Using a Searchable DVH Database. Med Phys. 2012 Jun; 39(6Part24):3908.
View in: PubMed

Look Hong NJ, Pandalai PK, Hornick JL, Shekar PS, Harmon DC, Chen YL, Butrynski JE, Baldini EH, Raut CP. Cardiac angiosarcoma management and outcomes: 20-year single-institution experience. Ann Surg Oncol. 2012 Aug; 19(8):2707-15.
View in: PubMed

Boni C, Tiseo M, Boni L, Baldini E, Recchia F, Barone C, Grossi F, Germano D, Matano E, Marini G, Labianca R, Di Costanzo F, Bagnulo A, Pennucci C, Caroti C, Mencoboni M, Zanelli F, Prochilo T, Cafferata MA, Ardizzoni A. Triplets versus doublets, with or without cisplatin, in the first-line treatment of stage IIIB-IV non-small cell lung cancer (NSCLC) patients: a multicenter randomised factorial trial (FAST). Br J Cancer. 2012 Feb 14; 106(4):658-65.
View in: PubMed

Sorrenti S, Guaitoli E, Catania A, D'Andrea V, Di Matteo FM, Nardi M, Prinzi N, Nardi F, Ascoli V, Baldini E, Ulisse S, De Antoni E. Surgical strategies in patients with medullary thyroid carcinoma. Clin Ter. 2012; 163(5):e303-6.
View in: PubMed

Kelly PJ, Mannarino E, Lewis JH, Baldini EH, Hacker FL. Total dural irradiation: RapidArc versus static-field IMRT: a case study. Med Dosim. 2012; 37(2):175-81.
View in: PubMed

Mak RH, Doran E, Muzikansky A, Kang J, Neal JW, Baldini EH, Choi NC, Willers H, Jackman DM, Sequist LV. Outcomes after combined modality therapy for EGFR-mutant and wild-type locally advanced NSCLC. Oncologist. 2011; 16(6):886-95.
View in: PubMed

Raut CP, George S, Hornick JL, Butrynski JE, Morgan JA, Ready J, Nascimento AF, Fletcher CD, Demetri GD, Baldini EH. High rates of histopathologic discordance in sarcoma with implications for clinical care. J Clin Oncol. 2011 May 20; 29(15_suppl):10065.
View in: PubMed

Suppa M, Boccardo C, Cavicchi F, Contu E, Valeriani L, Colzi M, Giancaspro G, Scarpellini MG, Coppola A, Baldini E, Aguglia F. [The use of cardiac markers bed test in acute coronary syndrome in emergency department]. Clin Ter. 2011; 162(1):7-10.
View in: PubMed

Haglund KE, Raut CP, Nascimento AF, Wang Q, George S, Baldini EH. Recurrence patterns and survival for patients with intermediate- and high-grade myxofibrosarcoma. Int J Radiat Oncol Biol Phys. 2012 Jan 01; 82(1):361-7.
View in: PubMed

Abraham JA, Baldini EH, Butrynski JE. Management of adult soft-tissue sarcoma of the extremities and trunk. Expert Rev Anticancer Ther. 2010 Feb; 10(2):233-48.
View in: PubMed

Sofia S, Baldini E, Zhuzhuni H, Velardi CA, Maffongelli E, Ovani A, Coppola A, Suppa M, Scarpellini MG. [The role of D-dimer in aortic dissection]. Clin Ter. 2010; 161(1):45-8.
View in: PubMed

Caglar HB, Baldini EH, Othus M, Rabin MS, Bueno R, Sugarbaker DJ, Mentzer SJ, Jänne PA, Johnson BE, Allen AM. Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery. Cancer. 2009 Sep 15; 115(18):4156-66.
View in: PubMed

Baldini EH. Radiation therapy options for malignant pleural mesothelioma. Semin Thorac Cardiovasc Surg. 2009; 21(2):159-63.
View in: PubMed

Lawenda BD, Arnold MG, Tokarz VA, Silverstein JR, Busse PM, McIntyre JF, Deschler DG, Baldini EH, Kachnic LA. Analysis of radiation therapy for the control of Merkel cell carcinoma of the head and neck based on 36 cases and a literature review. Ear Nose Throat J. 2008 Nov; 87(11):634-43.
View in: PubMed

Allen AM, Mentzer SJ, Yeap BY, Soto R, Baldini EH, Rabin MS, Sugarbaker DJ, Bueno R. Pneumonectomy after chemoradiation: the Dana-Farber Cancer Institute/Brigham and Women's Hospital experience. Cancer. 2008 Mar 01; 112(5):1106-13.
View in: PubMed

Del Mastro L, Dozin B, Aitini E, Catzeddu T, Baldini E, Contu A, Durando A, Danese S, Cavazzini G, Canavese G, Bruzzi P, Pronzato P, Venturini M. Timing of adjuvant chemotherapy and tamoxifen in women with breast cancer: findings from two consecutive trials of Gruppo Oncologico Nord-Ovest-Mammella Intergruppo (GONO-MIG) Group. Ann Oncol. 2008 Feb; 19(2):299-307.
View in: PubMed

Ito H, Hornick JL, Bertagnolli MM, George S, Morgan JA, Baldini EH, Wagner AJ, Demetri GD, Raut CP. Leiomyosarcoma of the inferior vena cava: survival after aggressive management. Ann Surg Oncol. 2007 Dec; 14(12):3534-41.
View in: PubMed

Allen AM, Den R, Wong JS, Zurakowski D, Soto R, Jänne PA, Zellos L, Bueno R, Sugarbaker DJ, Baldini EH. Influence of radiotherapy technique and dose on patterns of failure for mesothelioma patients after extrapleural pneumonectomy. Int J Radiat Oncol Biol Phys. 2007 Aug 01; 68(5):1366-74.
View in: PubMed

Lucchi M, Melfi F, Baldini E, Fontanini G, Boni G, Viti A, Mussi A. Sentinel lymph node mapping: detection of micrometastases by polymerase chain reaction in non-small cell lung cancer. J Thorac Oncol. 2007 May; 2(5 Suppl):S37.
View in: PubMed

Allen AM, Czerminska M, Jänne PA, Sugarbaker DJ, Bueno R, Harris JR, Court L, Baldini EH. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma. Int J Radiat Oncol Biol Phys. 2006 Jul 01; 65(3):640-5.
View in: PubMed

Allen AM, Den R, Wong JS, Janne PA, Zurakowski D, Soto R, Bueno R, Sugarbaker DJ, Baldini EH. The influence of radiotherapy technique and dose on the patterns of failure for mesothelioma patients following extrapleural pneumonectomy. J Clin Oncol. 2006 Jun 20; 24(18_suppl):7094.
View in: PubMed

Tibaldi C, Prochilo T, Russo F, Pennucci MC, Del Freo A, Innocenti F, Fabbri A, Falcone A, Conte PF, Baldini E. Epirubicin/paclitaxel/etoposide in extensive-stage small-cell lung cancer: a phase I-II study. Br J Cancer. 2006 May 08; 94(9):1263-6.
View in: PubMed

Novello S, Baldini E. Women and lung cancer. Ann Oncol. 2006 Mar; 17 Suppl 2:ii79-82.
View in: PubMed

Mamon HJ, Yeap BY, Jänne PA, Reblando J, Shrager S, Jaklitsch MT, Mentzer S, Lukanich JM, Sugarbaker DJ, Baldini EH, Berman S, Skarin A, Bueno R. High risk of brain metastases in surgically staged IIIA non-small-cell lung cancer patients treated with surgery, chemotherapy, and radiation. J Clin Oncol. 2005 Mar 01; 23(7):1530-7.
View in: PubMed

Baldini EH. External beam radiation therapy for the treatment of pleural mesothelioma. Thorac Surg Clin. 2004 Nov; 14(4):543-8.
View in: PubMed

Jänne PA, Baldini EH. Patterns of failure following surgical resection for malignant pleural mesothelioma. Thorac Surg Clin. 2004 Nov; 14(4):567-73.
View in: PubMed

Mamon HJ, Yeap B, Reblando J, Shrager S, Jaklitsch MT, Lukanich JM, Sugarbaker DJ, Baldini E, Janne P, Bueno R. High risk of brain metastases in surgically staged IIIA NSCLC patients treated with surgery, chemotherapy and radiation. J Clin Oncol. 2004 Jul 15; 22(14_suppl):7173.
View in: PubMed

Baldini E, Prochilo T, Salvadori B, Bolognesi A, Aldrighetti D, Venturini M, Rosso R, Carnino F, Gallo L, Giannessi P, Conte PF, Orlandini C, Bruzzi P. Multicenter randomized phase III trial of epirubicin plus paclitaxel vs epirubicin followed by paclitaxel in metastatic breast cancer patients: focus on cardiac safety. Br J Cancer. 2004 Jul 05; 91(1):45-9.
View in: PubMed

Cross CK, Berman S, Buswell L, Johnson B, Baldini EH. Prospective study of palliative hypofractionated radiotherapy (8.5 Gy x 2) for patients with symptomatic non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2004 Mar 15; 58(4):1098-105.
View in: PubMed

Baldini E, Gardin G, Giannessi PG, Evangelista G, Roncella M, Prochilo T, Collecchi P, Rosso R, Lionetto R, Bruzzi P, Mosca F, Conte PF. Accelerated versus standard cyclophosphamide, epirubicin and 5-fluorouracil or cyclophosphamide, methotrexate and 5-fluorouracil: a randomized phase III trial in locally advanced breast cancer. Ann Oncol. 2003 Feb; 14(2):227-32.
View in: PubMed

Galper S, Gelman R, Recht A, Silver B, Kohli A, Wong JS, Van Buren T, Baldini EH, Harris JR. Second nonbreast malignancies after conservative surgery and radiation therapy for early-stage breast cancer. Int J Radiat Oncol Biol Phys. 2002 Feb 01; 52(2):406-14.
View in: PubMed

Baldini E, Ardizzoni A, Prochilo T, Cafferata MA, Boni L, Tibaldi C, Neumaier C, Conte PF, Rosso R. Gemcitabine, Ifosfamide and Navelbine (GIN): activity and safety of a non-platinum-based triplet in advanced non-small-cell lung cancer (NSCLC). Br J Cancer. 2001 Nov 16; 85(10):1452-5.
View in: PubMed

Esnaola NF, Rubin BP, Baldini EH, Vasudevan N, Demetri GD, Fletcher CD, Singer S. Response to chemotherapy and predictors of survival in adult rhabdomyosarcoma. Ann Surg. 2001 Aug; 234(2):215-23.
View in: PubMed

Conte PF, Gennari A, Donati S, Salvadori B, Baldini E, Bengala C, Pazzagli I, Orlandini C, Danesi R, Fogli S, Del Tacca M. Gemcitabine plus epirubicin plus taxol (GET) in advanced breast cancer: a phase II study. Breast Cancer Res Treat. 2001 Jul; 68(2):171-9.
View in: PubMed

Killoran JH, Baldini EH, Beard CJ, Chin L. A technique for optimization of digitally reconstructed radiographs of the chest in virtual simulation. Int J Radiat Oncol Biol Phys. 2001 Jan 01; 49(1):231-9.
View in: PubMed

Singer S, Demetri GD, Baldini EH, Fletcher CD. Management of soft-tissue sarcomas: an overview and update. Lancet Oncol. 2000 Oct; 1:75-85.
View in: PubMed

Baldini E, Silvano G, Tibaldi C, Campoccia S, Cionini L, Conte P. Sequential chemoradiation therapy with vinorelbine, ifosfamide, and cisplatin in stage IIIB non-small cell lung cancer: a phase II study. Semin Oncol. 2000 Feb; 27(1 Suppl 1):28-32.
View in: PubMed

Baldini EH, Goldberg J, Jenner C, Manola JB, Demetri GD, Fletcher CD, Singer S. Long-term outcomes after function-sparing surgery without radiotherapy for soft tissue sarcoma of the extremities and trunk. J Clin Oncol. 1999 Oct; 17(10):3252-9.
View in: PubMed

Baldini EH, Demetri GD, Fletcher CD, Foran J, Marcus KC, Singer S. Adults with Ewing's sarcoma/primitive neuroectodermal tumor: adverse effect of older age and primary extraosseous disease on outcome. Ann Surg. 1999 Jul; 230(1):79-86.
View in: PubMed

Collecchi P, Passoni A, Rocchetta M, Gnesi E, Baldini E, Bevilacqua G. Cyclin-D1 expression in node-positive (N+) and node-negative (N-) infiltrating human mammary carcinomas. Int J Cancer. 1999 Apr 20; 84(2):139-44.
View in: PubMed

Baldini EH, DeCamp MM, Katz MS, Berman SM, Swanson SJ, Mentzer SJ, Bueno R, Sugarbaker DJ. Patterns of recurrence and outcome for patients with clinical stage II non-small-cell lung cancer. Am J Clin Oncol. 1999 Feb; 22(1):8-14.
View in: PubMed

Gugenheim J, Baldini E, Pommier Bernard G, Goubaux B, Mouiel J. Prognostic value of crossmatch in liver transplantation. Transplant Proc. 1999 Feb-Mar; 31(1-2):552-3.
View in: PubMed

Baldini E, Gugenheim J, Ouzan D, Katkhouda N, Mouiel J. Orthotopic liver transplantation with and without peritoneal drainage: a comparative study. Transplant Proc. 1999 Feb-Mar; 31(1-2):556-7.
View in: PubMed

Sugarbaker DJ, Flores RM, Jaklitsch MT, Richards WG, Strauss GM, Corson JM, DeCamp MM, Swanson SJ, Bueno R, Lukanich JM, Baldini EH, Mentzer SJ. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg. 1999 Jan; 117(1):54-63; discussion 63-5.
View in: PubMed

Collecchi P, Baldini E, Giannessi P, Naccarato AG, Passoni A, Gardin G, Roncella M, Evangelista G, Bevilacqua G, Conte PF. Primary chemotherapy in locally advanced breast cancer (LABC): effects on tumour proliferative activity, bcl-2 expression and the relationship between tumour regression and biological markers. Eur J Cancer. 1998 Oct; 34(11):1701-4.
View in: PubMed

Toouli J, Baldini E, Casaccia M, Gugenheim J, Migliori G, Mouiel J. Outcome of laparoscopic transabdominal preperitoneal inguinal hernia repair. Surg Laparosc Endosc. 1998 Jun; 8(3):223-6.
View in: PubMed

Baldini E, Tibaldi C, Ardizzoni A, Salvati F, Antilli A, Portalone L, Barbera S, Romano F, De Marinis F, Migliorino MR, Noseda MA, Borghini U, Crippa M, Ferrara G, Raimondi M, Fioretti M, Bandera M, Pennucci MC, Galeasso G, Cacciani GC, Lepidini G, Sunseri G, Lanfranco C, Rinaldi M, Rosso R, et al. Cisplatin-vindesine-mitomycin (MVP) vs cisplatin-ifosfamide-vinorelbine (PIN) vs carboplatin-vinorelbine (CaN) in patients with advanced non-small-cell lung cancer (NSCLC): a FONICAP randomized phase II study. Italian Lung Cancer Task Force (FONICAP). Br J Cancer. 1998 Jun; 77(12):2367-70.
View in: PubMed

Samuel D, Bismuth H, Boillot O, Ducerf C, Baulieux J, Gugenheim J, Baldini E, Launois B, Messner M, Wolf P, Ellero E, Domergue J, Pageaux J, Cherqui D, Duvoux C, Durand F, Belghiti J, Calmus Y, Massault PP, Neau-Cransac M, Saric J, LeTreut Y, Campan P. Tacrolimus (FK506)-based dual versus triple therapy following liver transplantation. Transplant Proc. 1998 Jun; 30(4):1394-6.
View in: PubMed

Baldini E, Tibaldi C, Chiavacci F, Di Lieto M, Fioretto L, Giallom-bardo A, Taviani R, Ghezzi P, Bolognini A, Conte P. Epirubicin/vinorelbine as first line therapy in metastatic breast cancer. Breast Cancer Res Treat. 1998 May; 49(2):129-34.
View in: PubMed

Monson JM, Stark P, Reilly JJ, Sugarbaker DJ, Strauss GM, Swanson SJ, Decamp MM, Mentzer SJ, Baldini EH. Clinical radiation pneumonitis and radiographic changes after thoracic radiation therapy for lung carcinoma. Cancer. 1998 Mar 01; 82(5):842-50.
View in: PubMed

Baldini EH, Strauss GM. Women and lung cancer: waiting to exhale. Chest. 1997 Oct; 112(4 Suppl):229S-234S.
View in: PubMed

Baldini E, Gardin G, Giannessi P, Brema F, Camorriano A, Carnino F, Naso C, Pastorino G, Pronzato P, Rosso R, Rubagotti A, Torretta G, Conte PF. A randomized trial of chemotherapy with or without estrogenic recruitment in locally advanced breast cancer. North-West Oncology Group (GONO) Study, Italy. Tumori. 1997 Sep-Oct; 83(5):829-33.
View in: PubMed

Conte PF, Baldini E, Gennari A, Michelotti A, Salvadori B, Tibaldi C, Danesi R, Innocenti F, Gentile A, Dell'Anna R, Biadi O, Mariani M, Del Tacca M. Dose-finding study and pharmacokinetics of epirubicin and paclitaxel over 3 hours: a regimen with high activity and low cardiotoxicity in advanced breast cancer. J Clin Oncol. 1997 Jul; 15(7):2510-7.
View in: PubMed

Elias AD, Skarin AT, Leong T, Mentzer S, Strauss G, Lynch T, Shulman L, Jacobs C, Abner A, Baldini EH, Frei E, Sugarbaker DJ. Neoadjuvant therapy for surgically staged IIIA N2 non-small cell lung cancer (NSCLC). Lung Cancer. 1997 May; 17(1):147-61.
View in: PubMed

Baldini E, Tibaldi C, Lencioni M, Giannessi P, Evangelista G, Roncella M, Spinelli C, Meucci C, da Prato M, Conte P. Filgrastim and lack of support of intensive adjuvant chemotherapy for high-risk breast cancer patients. Am J Clin Oncol. 1997 Apr; 20(2):169-72.
View in: PubMed

Baldini EH. Palliative radiation therapy for non-small cell lung cancer. Hematol Oncol Clin North Am. 1997 Apr; 11(2):303-19.
View in: PubMed

Gugenheim J, Baldini E, Ouzan D, Mouiel J. Absence of initial viral replication and long-term high dose immunoglobulin administration improve results of hepatitis B virus recurrence prophylaxis after liver transplantation. Transplant Proc. 1997 Feb-Mar; 29(1-2):517-8.
View in: PubMed

Baldini EH, Recht A, Strauss GM, DeCamp MM, Swanson SJ, Liptay MJ, Mentzer SJ, Sugarbaker DJ. Patterns of failure after trimodality therapy for malignant pleural mesothelioma. Ann Thorac Surg. 1997 Feb; 63(2):334-8.
View in: PubMed

Gugenheim J, Baldini E, Casaccia M, Ouzan D, Saint-Paul MC, Mouiel J. [Hepatic resection and transplantation for hepatocellular carcinoma in patients with cirrhosis]. Gastroenterol Clin Biol. 1997; 21(8-9):590-5.
View in: PubMed

Baldini E, Tibaldi C, Pfanner E, Ricci S, Falcone A, Ceribelli A, Sarcina R, Comella G, Stampino CG, Conte PF. Phase II study of oral doxifluridine in elderly patients with advanced non-small-cell lung cancer. Am J Clin Oncol. 1996 Dec; 19(6):592-4.
View in: PubMed

Conte PF, Michelotti A, Baldini E, Salvadori B, Gennari A, Da Prato M, Tibaldi C, Salzano E, Gentile A. A dose-finding study of epirubicin in combination with paclitaxel in the treatment of advanced breast cancer. Semin Oncol. 1996 Oct; 23(5 Suppl 11):28-31.
View in: PubMed

Michelotti A, Gennari A, Salvadori B, Giannessi PG, Baldini E, Tibaldi C, Da Prato M, Conte PF. Paclitaxel in combination with vinorelbine in pretreated advanced breast cancer patients. Semin Oncol. 1996 Oct; 23(5 Suppl 11):38-40.
View in: PubMed

Michelotti A, Gennari A, Salvadori B, Tognoni A, Tibaldi C, Baldini E, Conte PF. Paclitaxel and vinorelbine in anthracycline-pretreated breast cancer: a phase II study. Ann Oncol. 1996 Oct; 7(8):857-60.
View in: PubMed

Baldini E, Tibaldi C, Chella A, Angeletti CA, Silvano G, Andrei A, Algeri R, Conte PF. Phase II study of vinorelbine/ifosfamide/cisplatin for the treatment of advanced non-small-cell lung cancer. Ann Oncol. 1996 Sep; 7(7):747-9.
View in: PubMed

Tibaldi C, Baldini E, Ricci S, Conte PF. A pilot study with cisplatin, ifosfamide and weekly administration of vinorelbine as an outpatient combination chemotherapy for advanced non small cell lung cancer. Anticancer Res. 1996 Sep-Oct; 16(5B):3213-5.
View in: PubMed

Conte PF, Baldini E, Gardin G, Pronzato P, Amadori D, Carnino F, Monzeglio C, Gentilini P, Gallotti P, DeMicheli R, Venturini M, Rubagotti A, Rosso R. Chemotherapy with or without estrogenic recruitment in metastatic breast cancer. A randomized trial of the Gruppo Oncologico Nord Ovest (GONO). Ann Oncol. 1996 Jul; 7(5):487-90.
View in: PubMed

Collecchi P, Giannessi PG, Baldini E, Naccarato AG, Passoni A, Bevilacqua G, Conte PF. Effects of primary chemotherapy on biological parameters of locally advanced breast cancer. Ann N Y Acad Sci. 1996 Apr 30; 784:419-26.
View in: PubMed

Singer S, Baldini EH, Demetri GD, Fletcher JA, Corson JM. Synovial sarcoma: prognostic significance of tumor size, margin of resection, and mitotic activity for survival. J Clin Oncol. 1996 Apr; 14(4):1201-8.
View in: PubMed

Ardizzoni A, Addamo GF, Baldini E, Borghini U, Portalone L, De Marinis F, Lionetto R, Conte PF, Bruzzi P, Pennucci MC, et al. Mitomycin-ifosfamide-cisplatinum (MIP) vs MIP-interferon vs cisplatinum-carboplatin in metastatic non-small-cell lung cancer: a FONICAP randomised phase II study. Italian Lung Cancer Task Force. Br J Cancer. 1995 Jan; 71(1):115-9.
View in: PubMed

Baldini E, Tibaldi C, Chella A, Angeletti CA, Romanini A, Andrei A, Algeri R, Silvano G, Conte PF. Combination chemotherapy with vinorelbine, ifosfamide, and cisplatin: a phase II study in stage IIIB-IV non-small cell lung cancer. Semin Oncol. 1994 Jun; 21(3 Suppl 4):12-5.
View in: PubMed

Ardizzoni A, Bonavia M, Viale M, Baldini E, Mereu C, Verna A, Ferrini S, Cinquegrana A, Molinari S, Mariani GL, et al. Biologic and clinical effects of continuous infusion interleukin-2 in patients with non-small cell lung cancer. Cancer. 1994 Mar 01; 73(5):1353-60.
View in: PubMed

Gugenheim J, Baldini E, Mazza D, Fabiani P, St Paul MC, Goubaux B, Ouzan D, Mouiel J. Recurrence of hepatitis C virus after liver transplantation. Transpl Int. 1994; 7 Suppl 1:S224-6.
View in: PubMed

Campora E, Pronzato P, Amoroso D, Bertelli GF, Venturini M, Baldini E, Brunetti I, Sertoli MR, Conte P, Rosso R. Prognostic factors in node positive primary breast cancer patients treated with adjuvant CMF. Anticancer Res. 1992 Sep-Oct; 12(5):1555-8.
View in: PubMed

Ardizzoni A, Rosso R, Salvati F, Scagliotti G, Soresi E, Ferrara G, Pennucci C, Baldini E, Cruciani AR, Antilli A, et al. Combination chemotherapy and interferon alpha 2b in the treatment of advanced non-small-cell lung cancer. The Italian Lung Cancer Task Force (FONICAP). Am J Clin Oncol. 1991 Apr; 14(2):120-3.
View in: PubMed

Ardizzoni A, Fusco V, Pennucci C, Baldini E, Orsatti M, Vitale V, Bonavia M, Baracco F, Mereu C, Rosso R. Alternating chemotherapy with cyclophosphamide, doxorubicin, vincristine and cisplatin, etoposide followed by prophylactic cranial and thoracic irradiation for small cell lung cancer (SCLC): long-term results. Anticancer Res. 1991 Mar-Apr; 11(2):681-4.
View in: PubMed

Campora E, Baldini E, Rubagotti A, Chiara S, Bruzzi P, Sertoli MR, Rosso R. Double-blind randomized trial of lorazepam versus placebo with methylprednisolone for control of emesis due to non-cisplatin containing chemotherapy. J Chemother. 1990 Oct; 2(5):336-9.
View in: PubMed

Ardizzoni A, Sertoli MR, Corcione A, Pennucci MC, Baldini E, Intra E, Ferrarini M, Rosso R, Mazzanti P, Pistoia V. Accelerated chemotherapy with or without GM-CSF for small cell lung cancer: a non-randomised pilot study. Eur J Cancer. 1990; 26(9):937-41.
View in: PubMed

Scaramuzzi M, Amorotti C, De Palma M, Falchi AM, Baldini E, De Maria D, Casolo P. Clinical evaluation of CA 15.3 in the post-operative follow-up of breast cancer patients. Int J Biol Markers. 1990 Jan-Mar; 5(1):22-6.
View in: PubMed

Secchi Trinelli E, Baldini E. [Clinical testing of the validity of a treatment with a base of adrenal cortex extract in combination with hematoporphyrin and vitamin factors in some adynamic syndromes]. Clin Ter. 1969 Sep 15; 50(5):427-36.
View in: PubMed

Research Departments:

Location

Dana-Farber Cancer Institute
450 Brookline Avenue
Boston MA, 02215
Get Directions

Top